Global Cell Therapy Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Cell Therapy Market In The Period 2029-2034?

The rheumatology therapeutics market size has consistently expanded in recent years. It is anticipated to increase from $42.4 billion in 2024 to $44.18 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.2%. This historical growth can be linked to factors like the escalating prevalence of rheumatologic conditions, the global rise in the aging demographic, improved awareness concerning therapeutic alternatives, innovations in biological treatments, and the wider availability of healthcare services in emerging markets.

The rheumatology therapeutics market is projected to experience consistent expansion in the coming years. By 2029, it is anticipated to reach $52.25 billion, demonstrating a compound annual growth rate (CAGR) of 4.3%. This growth during the forecast period is attributable to several factors, including a move towards personalized medicine, the increasing use of biosimilars in rheumatology, higher investment in research and development, the incorporation of digital health technologies, and regulatory clearances for new treatments. Key trends for the same period encompass an increase in telemedicine and remote monitoring, the development of more targeted therapies for distinct rheumatic conditions, a focus on patient-centric care, the broadening of biologic treatments beyond monoclonal antibodies, and the implementation of value-based pricing structures.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp

What Strategic Drivers Are Accelerating The Cell Therapy Market Expansion?

The increasing occurrence of autoimmune conditions is anticipated to fuel the expansion of the rheumatology therapeutics market in the future. An autoimmune disorder is characterized by the immune system erroneously targeting and harming the body’s own tissues. The uptick in autoimmune disease prevalence can be attributed to a mix of genetic, environmental, and lifestyle elements, along with heightened awareness and enhanced diagnostic tools. Rheumatology treatments are essential for autoimmune conditions to control inflammation, ease discomfort, and avert damage to joints and tissues resulting from the immune system’s assault on the body. For example, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that approximately 514,000 individuals in Australia, constituting 2.0% of the population, were estimated to have rheumatoid arthritis in 2022. In 2023, rheumatoid arthritis represented 2.0% of the overall disease burden and 16% of the burden associated with all musculoskeletal conditions. Consequently, the increasing incidence of autoimmune diseases is a key factor boosting the expansion of the rheumatology therapeutics market.

What Is The Detailed Segment Distribution Of The Cell Therapy Market?

The rheumatology therapeutics market covered in this report is segmented –

1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications

Subsegments:

1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs

3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids

4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase

5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics

How Are Global Trends Impacting The Development Of The Cell Therapy Market?

Companies operating within the rheumatology therapeutics market are actively developing innovative solutions, such as intravenous (IV) formulations, to improve the effectiveness of treatments and enhance patient convenience. An intravenous (IV) formulation refers to a medication or substance directly delivered into a vein using a needle or catheter. As an illustration, in October 2023, the Switzerland-based pharmaceutical company Novartis AG announced that the US Food and Drug Administration (FDA) had approved Cosentyx, an intravenous (IV) formulation. This particular form of Cosentyx is uniquely approved for the treatment of adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). It operates by specifically targeting and inhibiting interleukin-17A (IL-17A) and represents the sole non-tumor necrosis factor alpha (TNF-a) IV treatment available for these conditions.

Who Are The Major Stakeholders Operating In The Cell Therapy Market?

Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Cell Therapy Market?

North America was the largest region in the rheumatology therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=17246&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2025, By The Business Research Company

Rheumatoid Arthritis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Leukemia Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

Bipolar Disorder Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795